Related Experiment Videos
Cholecystokinin in the entero-insular axis
Y Okabayashi1, M Otsuki, S Baba
1Second Department of Internal Medicine, Kobe University School of Medicine, Japan.
Diabetes Research and Clinical Practice
|January 1, 1989
Summary
Cholecystokinin (CCK), a gastrointestinal hormone, acts as an incretin, enhancing insulin release and glucose sensitivity. Its specific role in diseases requires further investigation using advanced techniques.
Area of Science:
- Endocrinology
- Gastroenterology
- Metabolic Research
Background:
- Cholecystokinin (CCK) is a key gastrointestinal hormone released post-meal.
- CCK influences the gallbladder, exocrine pancreas, and endocrine pancreas.
- The entero-insular axis integrates gut hormones and insulin secretion.
Purpose of the Study:
- To review the role of CCK within the entero-insular axis.
- To explore CCK's function as an incretin and its impact on insulin release.
- To discuss the potential of CCK in disease states and future research directions.
Main Methods:
- Literature review focusing on the entero-insular axis.
- Analysis of CCK's synergistic effects with other incretins.
- Discussion of methodologies for future pathophysiological studies.
Main Results:
- CCK functions as an incretin, synergistically enhancing insulin release with other incretin components.
- CCK increases the sensitivity of pancreatic beta cells to glucose stimulation.
- The precise role of CCK in disease pathophysiology remains to be fully elucidated.
Conclusions:
- CCK is a significant component of the entero-insular axis, modulating insulin secretion.
- Further research utilizing CCK-specific assays and receptor antagonists is crucial.
- Understanding CCK's role in disease states holds potential for therapeutic insights.